Works matching IS 00302414 AND DT 2023 AND VI 101 AND IP 10

Results: 8

Front & Back Matter.

Published in:: Oncology, 2023, v. 101, n. 10, p. 1, doi. 10.1159/000534426
Publication type:: Article

Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2023, v. 101, n. 10, p. 655, doi. 10.1159/000531689

By:

Takada, Hitomi;
Yamashita, Koji;
Osawa, Leona;
Komiyama, Yasuyuki;
Nakakuki, Natsuko;
Muraoka, Masaru;
Suzuki, Yuichiro;
Sato, Mitsuaki;
Kobayashi, Shoji;
Yoshida, Takashi;
Takano, Shinichi;
Maekawa, Shinya;
Enomoto, Nobuyuki

Publication type:

Article

Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular Carcinoma.

Published in:

Oncology, 2023, v. 101, n. 10, p. 634, doi. 10.1159/000531562

By:

Nagai, Hidenari;
Amanuma, Makoto;
Mukozu, Takanori;
Kobayashi, Kojiro;
Nagumo, Hideki;
Mohri, Kunihide;
Watanabe, Go;
Yoshimine, Naoyuki;
Ogino, Yu;
Daido, Yasuko;
Matsukiyo, Yasushi;
Matsui, Teppei;
Wakui, Noritaka;
Momiyama, Koichi;
Higai, Koji;
Matsuda, Takahisa;
Igarashi, Yoshinori

Publication type:

Article

Intralesional Chemotherapy for Prostate Cancer: In vivo Proof of Principle.

Published in:

Oncology, 2023, v. 101, n. 10, p. 645, doi. 10.1159/000531494

By:

Jotatsu, Yura;
Shigemura, Katsumi;
Arbiser, Jack L;
Moriwaki, Michika;
Hirata, Yuto;
Maeda, Koki;
Yang, Young-min;
Fujisawa, Masato

Publication type:

Article

Recent Developments in Diagnostic and Prognostic Biomarkers for Colorectal Cancer: A Narrative Review.

Published in:

Oncology, 2023, v. 101, n. 10, p. 675, doi. 10.1159/000531474

By:

Giannopoulou, Nefeli;
Constantinou, Constantina

Publication type:

Article

Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance Database.

Published in:

Oncology, 2023, v. 101, n. 10, p. 664, doi. 10.1159/000531390

By:

Yamaoka, Kenta;
Fujiwara, Masaki;
Uchida, Mayako;
Uesawa, Yoshihiro;
Muroi, Nobuyuki;
Shimizu, Tadashi

Publication type:

Article

Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

Published in:

Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2023, v. 101, n. 10, p. 609, doi. 10.1159/000531111

By:

Takada, Hitomi;
Yamashita, Koji;
Osawa, Leona;
Komiyama, Yasuyuki;
Nakakuki, Natsuko;
Muraoka, Masaru;
Suzuki, Yuichiro;
Sato, Mitsuaki;
Takano, Shinichi;
Fukasawa, Mitsuharu;
Yamaguchi, Tatsuya;
Maekawa, Shinya;
Takahashi, Kazuya;
Uchimura, Kohei;
Enomoto, Nobuyuki

Publication type:

Article